André Larente
President - Director
Under his leadership, DIAGNOS underwent a defining transformation, pivoting from large-scale data mining to advanced artificial intelligence dedicated to eye health. This shift was not only technological, but structural: André Larente successfully redefined the company’s DNA, anchoring it in the highly demanding medical device sector while preserving the agility required for breakthrough innovation.
His ability to navigate complex technology ecosystems enables him to lead large-scale business transformations where clinical rigor must meet software performance. He has overseen the development of an infrastructure capable of supporting the most demanding scientific validation cycles, positioning DIAGNOS not merely as a manufacturer, but as a true institutional sentinel for global health trajectories.
As the leader of a public company, he maintains a critical balance between exploring cutting-edge innovation and meeting market performance expectations. His vision is grounded in disciplined management: ensuring that every algorithmic breakthrough is protected, certified, and ultimately translated into tangible value. For shareholders, this means growth built on strong technological assets; for patients and clinicians, it means unprecedented access to technologies validated in real-world settings.
